CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- Open-market buys, last 90 days
- $226,500
- in 1 filing
- Open-market sales, last 90 days
- $4,661,919
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,435,419. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | Lewis William Director | Grant or award · Option (right to buy) | +32,500 | 32,500 | ||
| 2025-01-06 | van der Kamp Hilde Johanna Director | Grant or award · Option (right to buy) | +32,500 | 32,500 | ||
| 2025-01-06 | LANGE LOUIS G Director | Grant or award · Option (right to buy) | +32,500 | 32,500 | ||
| 2025-01-06 | Davidson Michael H. Chief Executive Officer | Grant or award · Option (right to buy) | +670,467 | 670,467 | ||
| 2025-01-02 | Kling Douglas F Chief Operating Officer | Grant or award · Option (right to buy) | +250,000 | 250,000 | ||
| 2025-01-02 | Kooij Louise Frederika Chief Accounting Officer | Grant or award · Option (right to buy) | +80,000 | 80,000 | ||
| 2025-01-02 | Audet Juliette Berangere Chief Business Officer | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2025-01-02 | Somaiya Mayur Ian Chief Financial Officer | Grant or award · Option (right to buy) | +220,000 | 220,000 | ||
| 2025-01-02 | JONES WILLIAM A JR Chief Commercial Officer | Grant or award · Option (right to buy) | +200,000 | 200,000 | ||
| 2025-01-02 | Kastelein Johannes Jacob Pieter Chief Scientific Officer | Grant or award · Option (right to buy) | +200,000 | 200,000 | ||
| 2024-12-30 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −29,846 | $25.54 | $762K | 10,656,172 |
| 2024-12-27 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −41,472 | $25.95 | $1.1M | 10,686,018 |
| 2024-12-26 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −33,438 | $26.01 | $870K | 10,727,490 |
| 2024-12-24 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −16,164 | $25.66 | $415K | 10,760,928 |
| 2024-12-23 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −25,132 | $25.49 | $641K | 10,777,092 |
| 2024-12-20 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −44,143 | $25.53 | $1.1M | 10,807,853 |
| 2024-12-20 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −5,629 | $26.13 | $147K | 10,802,224 |
| 2024-12-19 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −56,506 | $25.45 | $1.4M | 10,851,996 |
| 2024-12-18 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −54,518 | $25.72 | $1.4M | 10,954,712 |
| 2024-12-18 | ForGrowth NAP B.V. 10% owner | Sale 10b5-1 | −46,210 | $26.55 | $1.2M | 10,908,502 |
Page 13 of 15 · 300 trades